Overview A Phase 1 Study to Assess HM15275 in Healthy and Obese Subjects. Status: COMPLETED Trial end date: 2025-05-02 Target enrollment: Participant gender: Summary This Study is a Phase 1 Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM15275 in Healthy and Obese Subjects.Phase: PHASE1 Details Lead Sponsor: Hanmi Pharmaceutical Company Limited